RoActemra
Drug timelines are a Plus or Pro feature.
18 regulatory and trial events tracked for RoActemra, covering 2014-12-24 to 2026-08-13. Get the full timeline:
Most recent: EMA Authorised: RoActemra (tocilizumab) — Roche Registration GmbH